Trase
Governed AI agents for healthcare back-office work
Our take
Trase, co-founded by Joe Laws and Red Cell Partners founder Grant Verstandig, builds Trase Origin, an agentic AI operating system for regulated industries. In healthcare, its agents take on repeatable back-office work such as sorting and routing inbound faxes, patient access tasks, and revenue cycle workflows, with governance, audit trails, and HIPAA and SOC 2 compliance designed in from the start. The buyer is a health system operations or revenue cycle leader who wants AI agents that can pass a compliance review.
The company emerged from stealth in November 2025 with a $10.5M pre-seed and raised a $107M seed led by ARCH Venture Partners in June 2026, one of the largest seed rounds in healthcare AI. Its flagship deployment is Duke Health, where agents triage the 5,000-plus monthly faxes in Duke's cardiology department 7.1 times faster than manual processing, saving roughly 1,395 staff hours per month and about $285,000 in annual staff capacity. The U.S. Navy is also a customer, and Trase charges customers based on measured efficiency gains rather than flat license fees.
What it does
- AI agents for inbound fax triage and routing
- Patient access workflow automation
- Revenue cycle task automation
- HIPAA and SOC 2 compliant agent platform
- Governance and oversight controls for agent actions
Where it's strong
- Live health system deployment at Duke, where fax triage ran 7.1 times faster than manual processing and saved about 1,395 staff hours a month.
- The $107M seed led by ARCH Venture Partners gives it unusual capital depth for a company at this stage.
- Pricing tied to measured efficiency gains lowers the risk of paying for software that does not perform.
What buyers should weigh
- The company only came out of stealth in November 2025, so the reference base beyond Duke Health is thin.
- The platform spans healthcare, defense, and other regulated industries, so healthcare-specific product depth may lag single-focus rivals.
- Published results center on fax triage; patient access and RCM claims have less public evidence.
Latest
Raised a $107M seed round led by ARCH Venture Partners in June 2026 to scale its Trase Origin agent platform.
Also in RCM Automation Platforms
Notable
AI agents across intake, auth, and revenue workflows
Commure
AI platform for clinical documentation and revenue cycle work
GenHealth.ai
An agentic OS for healthcare administration
CombineHealth
Named AI agents that work the revenue cycle end to end
Track this market
First Pass covers RCM Automation Platforms and the rest of the getting-paid stack every week.